PMID- 38302672 OWN - NLM STAT- MEDLINE DCOM- 20240205 LR - 20240206 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 14 IP - 1 DP - 2024 Feb 1 TI - Analysis of m6A regulators related immune characteristics in ankylosing spondylitis by integrated bioinformatics and computational strategies. PG - 2724 LID - 10.1038/s41598-024-53184-z [doi] LID - 2724 AB - N6-methyladenosine (m6A) modification, as a common epigenetic modification, has been widely studied in autoimmune diseases. However, the role of m6A in the regulation of the immune microenvironment of ankylosing spondylitis (AS) remains unclear. Therefore, we aimed to investigate the effect of m6A modification on the immune microenvironment of AS. We first evaluated RNA modification patterns mediated by 26 m6A regulators in 52 AS samples and 20 healthy samples. Thereafter, an m6A related classifier composed of seven genes was constructed and could effectively distinguish healthy and AS samples. Then, the correlation between m6A regulators and immune characteristics were investigated, including infiltrating immunocytes, immune reactions activity, and human leukocyte antigen (HLA) genes expression. The results indicated that m6A regulators was closely correlated with immune characteristics. For example, EIF3A was significantly related to infiltrating immunocytes; IGF2BP2 and EIF3A were significant regulators in immune reaction of TGF-beta family member, and the expression of HLA-DPA1 and HLA-E were affected by EIF3A and ALKBH5. Next, two distinct m6A expression patterns were identified through unsupervised clustering analysis, and diverse immune characteristics were found between them. A total of 5889 m6A phenotype-related genes were obtained between the two expression patterns, and their biological functions were revealed. Finally, we validated the expression status of m6A modification regulators using two additional datasets. Our findings illustrate that m6A modifications play a critical role in the diversity and complexity of the AS immune microenvironment. CI - (c) 2024. The Author(s). FAU - Guo, Da AU - Guo D AD - Osteonecrosis and Joint Reconstruction Ward, Department of Joint Surgery, HongHui Hospital, Xi'an Jiaotong University, Xi'an, 710054, Shaanxi, China. FAU - Liu, Jiayi AU - Liu J AD - Xinglin College, Liaoning University of Traditional Chinese Medicine, Shenyang, 110167, Liaoning, China. FAU - Li, Shuang AU - Li S AD - Department of Neurology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, 710038, Shaanxi, China. FAU - Xu, Peng AU - Xu P AD - Osteonecrosis and Joint Reconstruction Ward, Department of Joint Surgery, HongHui Hospital, Xi'an Jiaotong University, Xi'an, 710054, Shaanxi, China. sousou369@163.com. LA - eng PT - Journal Article DEP - 20240201 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - W7IBY2BGAX (6-methyladenine) RN - JAC85A2161 (Adenine) RN - 0 (IGF2BP2 protein, human) RN - 0 (RNA-Binding Proteins) SB - IM MH - Humans MH - *Spondylitis, Ankylosing/genetics MH - *Autoimmune Diseases MH - Adenine MH - Computational Biology MH - RNA-Binding Proteins PMC - PMC10834589 COIS- The authors declare no competing interests. EDAT- 2024/02/02 00:42 MHDA- 2024/02/05 06:42 PMCR- 2024/02/01 CRDT- 2024/02/01 23:48 PHST- 2023/06/09 00:00 [received] PHST- 2024/01/29 00:00 [accepted] PHST- 2024/02/05 06:42 [medline] PHST- 2024/02/02 00:42 [pubmed] PHST- 2024/02/01 23:48 [entrez] PHST- 2024/02/01 00:00 [pmc-release] AID - 10.1038/s41598-024-53184-z [pii] AID - 53184 [pii] AID - 10.1038/s41598-024-53184-z [doi] PST - epublish SO - Sci Rep. 2024 Feb 1;14(1):2724. doi: 10.1038/s41598-024-53184-z.